Abstract
Background
Diabetes and its complications appear to be multifactorial. Substances with antioxidant potential have been used to protect enteric neurons in experimental diabetes.
Aim
This study evaluated the effects of supplementation with l-glutamine and l-glutathione on enteric neurons in the jejunum in diabetic rats.
Methods
Rats at 90 days of age were distributed into six groups: normoglycemic, normoglycemic supplemented with 2 % l-glutamine, normoglycemic supplemented with 1 % l-glutathione, diabetic (D), diabetic supplemented with 2 % l-glutamine (DG), and diabetic supplemented with 1 % l-glutathione (DGT). After 120 days, the jejunums were immunohistochemically stained for HuC/D+ neuronal nitric oxide synthase (nNOS) and vasoactive intestinal polypeptide (VIP). Western blot was performed to evaluate nNOS and VIP. Submucosal and myenteric neurons were quantitatively and morphometrically analyzed.
Results
Diabetic neuropathy was observed in myenteric HuC/D, nNOS, and VIP neurons (p < 0.05). In the submucosal plexus, diabetes did not change nitrergic innervation but increased VIPergic neuronal density and body size (p < 0.05). Supplementation with l-glutathione prevented changes in HuC/D neurons in the enteric plexus (p < 0.05), showing that supplementation with l-glutathione was more effective than with l-glutamine. Myenteric nNOS neurons in the DGT group exhibited a reduced density (34.5 %) and reduced area (p < 0.05). Submucosal neurons did not exhibit changes. The increase in VIP-expressing neurons was prevented in the submucosal plexus in the DG and DGT groups (p < 0.05).
Conclusion
Supplementation with l-glutathione exerted a better neuroprotective effect than l-glutamine and may prevent the development of enteric diabetic neuropathy.
Similar content being viewed by others
References
Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol.. 2012;9:286–294.
Gershon MD. The second brain: a groundbreaking new understanding of nervous disorders of the stomach and intestine. New York, NY: Harper Collins; 1999.
Srinivasan S, Wiley JW. New insights into neural injury, repair, and adaptation in visceral afferents and the enteric nervous system. Curr Opin Gastroenterol.. 2000;16:78–82.
Rodrigues MLC, Motta MEFA. Mechanisms and factors associated with gastrointestinal symptoms in patients with diabetes mellitus. J Pediatr. 2012;88:17–24.
Nezami BG, Srinivasan S. Enteric nervous system in the small intestine: pathophysiology and clinical implications. Curr Gastroenterol Rep. 2010;12:358–365.
Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 2004;25:612–628.
Chandrasekharan B, Anitha M, Blatt R, Shahnavaz N, et al. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil. 2011;23:e126–e131.
Sierra VAM. Manifestaciones gastrointestinales de la diabetes mellitus. Rev Col Gastroenterol.. 2006;21:39–56.
Zanoni JN, Buttow NC, Bazotte RB, Miranda-Neto MH. Evaluation of the population of NADPH-diaphorase-stained and myosin-V myenteric neurons in the ileum of chronically streptozotocin-diabetic rats treated with ascorbic acid. Auton Neurosci.. 2003;104:32–38.
Pereira RV, de Miranda-Neto MH, da Silva Souza ID, Zanoni JN. Vitamin E supplementation in rats with experimental diabetes mellitus: analysis of myosin-V and nNOS immunoreactive myenteric neurons from terminal ileum. J Mol Histol. 2008;39:595–603.
da Silva GG, Zanoni JN, Buttow NC. Neuroprotective action of Ginkgo biloba on the enteric nervous system of diabetic rats. World J Gastroenterol. 2011;17:898–905.
Lopes CRP, Ferreira PEB, Zanoni JN, Alves AMP, et al. Neuroprotective effect of quercetin on the duodenum enteric nervous system of streptozotocin-induced diabetic rats. Dig Dis Sci. 2012;57:3106–3115.
Pereira RV, Tronchini EA, Tashima CM, Alves EP, et al. l-glutamine supplementation prevents myenteric neuron loss and has gliatrophic effects in the ileum of diabetic rats. Dig Dis Sci. 2011;56:3507–3516.
Zanoni JN, Tronchini EA, Moure SA, Souza ID. Effects of l-glutamine supplementation on the myenteric neurons from the duodenum and cecum of diabetic rats. Arq Gastroenterol. 2011;48:66–71.
Tashima CM, Tronchini EA, Pereira RV, Bazotte RB, Zanoni JN. Diabetic rats supplemented with l-glutamine: a study of immunoreactive myosin-V myenteric neurons and the proximal colonic mucosa. Dig Dis Sci. 2007;52:1233–1241.
Cruzat VF, Petry ER, Tirapegui J. Glutamina: aspectos bioquímicos, metabólicos, moleculares e suplementação. Rev Bras Med Esporte.. 2009;15:392–397.
Ueno Y, Kizaki M, Nakagiri R, Kamiya T, et al. Dietary glutathione protects rats from diabetic nephropathy and neuropathy. J Nutr. 2002;132:897–900.
Bergmeyer HU, Bernet E. d-Glucose determination with glucose oxidase and peroxidase. In: Methods of Enzymatic Analysis, 2nd ed. New York, NY: Verlag Chemie-Academic Press; 1974:1205–1215.
Lin Z, Gao N, Hu HZ, Liu S, et al. Immunoreactivity of Hu proteins facilitates identification of myenteric neurones in guinea-pig small intestine. Neurogastroenterol Motil. 2002;14:197–204.
Wrzos HF, Cruz A, Polavarapu R, Shearer D, Ouyang A. Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats. Dig Dis Sci. 1997;42:2106–2110.
Costa M, Buffa R, Furness JB, Solcia E. Immunohistochemical localization of polypeptides in peripheral autonomic nerves using whole mount preparations. Histochemistry. 1980;65:157–165.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
Alves EPB, Alves AMP, Pereira RVF, Miranda-Neto MH, Zanoni JN. Immunohistochemical study of vasoactive intestinal peptide (VIP) enteric neurons in diabetic rats supplemented with l-glutamine. Nutr Neurosci.. 2010;13:43–51.
Tsai P-H, Liu J-J, Chiu W-C, Pai M-H, Yeh S-L. Effects of dietary glutamine on adhesion molecule expression and oxidative stress in mice with streptozotocin-induced type 1 diabetes. Clin Nutr.. 2011;30:124–129.
Voukali E, Shotton HR, Lincoln J. Selective responses of myenteric neurons to oxidative stress and diabetic stimuli. Neurogastroenterol Motil. 2011;23:e411–e964.
Tomlinson DR, Gardiner NJ. Glucose neurotoxicity. Nat Rev Neurosci. 2008;9:36–45.
Brownlee M. The pathobiology of diabetic complications a unifying mechanism. Diabetes. 2005;54:1615–1625.
Zanoni JN, Hernandes L, Bazotte RB, Miranda Neto MH. Terminal ileum submucous plexus: study of the VIP-ergic neurons of diabetic rats treated with ascorbic acid. Arq Neuropsiquiatr. 2002;60:32–37.
Chung SSM, Ho ECM, Lam KSL, Chung SK. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol. 2003;14:S233–S236.
Shotton HR, Lincoln J. Diabetes only affects nitric oxide synthase-containing myenteric neurons that do not contain heme oxygenase 2. Brain Res. 2006;1068:248–256.
Fregonesi CE, Molinari SL, Alves AM, Defani MA, et al. Morphoquantitative aspects of nitrergic myoenteric neurons from the stomach of diabetic rats supplemented with acetyl-l-carnitine. Anat Histol Embryol. 2005;34:93–97.
de Mello ST, de Miranda Neto MH, Zanoni JN, Furlan MM. Effects of insulin treatment on HuC/HuD, NADH diaphorase, and nNOS-positive myoenteric neurons of the duodenum of adult rats with acute diabetes. Dig Dis Sci. 2009;54:731–737.
Chandrasekharan B, Srinivasan S. Diabetes and the enteric nervous system. Neurogastroenterol Motil. 2007;19:951–960.
Wiley JW. The many faces of nitric oxide: cytotoxic, cytoprotective or both. Neurogastroenterol Motil. 2007;19:541–544.
Rivera LR, Poole DP, Thacker M, Furness JB. The involvement of nitric oxide synthase neurons in enteric neuropathies. Neurogastroenterol Motil. 2011;23:980–988.
Espey MG, Miranda KM, Thomas DD, Xavier S, et al. A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species. Ann NY Acad Sci.. 2002;962:195–206.
Lin Z, Sandgren K, Ekblad E. Increased expression of nitric oxide synthase in cultured neurons from adult rat colonic submucous ganglia. Auton Neurosci.. 2004;114:29–38.
Vacas E, Bajo AM, Schally AV, Sánchez-Chapado M, et al. Antioxidant activity of vasoactive intestinal peptide in HK2 human renal cells. Peptides. 2012;38:275–281.
See NA, Epstein ML, Dahl JL, Bass P. The myenteric plexus regulates cell growth in rat jejunum. J Auton Nerv Sys.. 1990;31:219–229.
Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005;59:365–373.
Jordão AA Jr, Chiarello PG, Bernardes MSM, Vannucchi H. Peroxidação lipídica e etanol: papel da glutationa reduzida e da vitamina E. Medicina.. 1998;32:434–449.
Daniel EE, Posey-Daniel V. Neuromuscular structures in opossum esophagus: role of interstitial cells of Cajal. Am J Physiol. 1984;246:G305–G315.
Choi KM, Gibbons SJ, Roeder JL, Lurken MS, et al. Regulation of interstitial cells of Cajal in the mouse gastric body by neuronal nitric oxide. Neurogastroenterol Motil. 2007;19:585–595.
Li ZS, Young HM, Furness JB. Do vasoactive intestinal peptide (VIP)-and nitric oxide synthase-immunoreactive terminals synapse exclusively with VIP cell bodies in the submucous plexus of the guinea-pig ileum? Cell Tissue Res. 1995;281:485–491.
Chino Y, Fujimura M, Kitahama K, Fujimiya M. Colocalization of NO and VIP in neurons of the submucous plexus in the rat intestine. Peptides. 2002;23:2245–2250.
Mourad FH, Barada KA, Abdel-Malak N, Rached NAB, et al. Interplay between nitric oxide and vasoactive intestinal polypeptide in inducing fluid secretion in rat jejunum. J Physiol. 2003;550:863–871.
Said SI, Berisha HI, Pakbaz H. N-methyl-d-aspartate receptors outside the central nervous system: activation causes acute lung injury that is mediated by nitric oxide synthesis and prevented by vasoactive intestinal peptide. Neuroscience. 1995;65:943–946.
Sengul G, Coskun S, Cakir M, Coban MK, et al. Neuroprotective effect of ACE inhibitors in glutamate-induced neurotoxicity: rat neuron culture study. Turk Neurosurg.. 2011;21:367–371.
Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother. 2003;57:145–155.
Acknowledgments
This work was supported by Fundação Araucaria—PR and the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hermes-Uliana, C., Panizzon, C.P.N.B., Trevizan, A.R. et al. Is l-Glutathione More Effective Than l-Glutamine in Preventing Enteric Diabetic Neuropathy?. Dig Dis Sci 59, 937–948 (2014). https://doi.org/10.1007/s10620-013-2993-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-013-2993-2